Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Infection and Drug Resistance | journal | 1.354 Q1 | 65 | 258 | 131 | 10627 | 532 | 128 | 3.15 | 41.19 | 43.17 | |
2 | Perspectives in Medicinal Chemistry | journal | 1.113 Q1 | 17 | 0 | 5 | 0 | 35 | 5 | 10.50 | 0.00 | 0.00 | |
3 | Drug Safety - Case Reports | journal | 1.025 Q2 | 3 | 0 | 3 | 0 | 10 | 3 | 10.00 | 0.00 | 0.00 | |
4 | Vascular Health and Risk Management | journal | 0.996 Q2 | 82 | 42 | 167 | 2066 | 614 | 165 | 2.86 | 49.19 | 41.31 | |
5 | OncoTargets and Therapy | journal | 0.986 Q2 | 86 | 866 | 1810 | 32684 | 5587 | 1796 | 3.16 | 37.74 | 40.40 | |
6 | Journal of Experimental Pharmacology | journal | 0.937 Q2 | 23 | 9 | 21 | 630 | 72 | 21 | 3.35 | 70.00 | 44.44 | |
7 | Clinical Pharmacology: Advances and Applications | journal | 0.897 Q2 | 34 | 18 | 53 | 782 | 139 | 52 | 3.05 | 43.44 | 45.12 | |
8 | Therapeutics and Clinical Risk Management | journal | 0.725 Q2 | 70 | 268 | 605 | 9943 | 1310 | 586 | 1.91 | 37.10 | 38.32 | |
9 | Biologics: Targets and Therapy | journal | 0.683 Q2 | 47 | 19 | 47 | 947 | 106 | 45 | 2.19 | 49.84 | 45.83 | |
10 | Australian Prescriber | journal | 0.587 Q2 | 40 | 59 | 237 | 745 | 269 | 115 | 1.06 | 12.63 | 52.46 | |
11 | Australian Journal of Pharmacy | journal | 0.154 Q4 | 5 | 117 | 450 | 744 | 14 | 343 | 0.04 | 6.36 | 57.14 | |
12 | Open Access Journal of Clinical Trials | journal | 0.143 Q4 | 15 | 5 | 20 | 221 | 16 | 20 | 0.64 | 44.20 | 45.83 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®